AG
ORGO icon

Algert Global’s Organogenesis Holdings ORGO Stock Holding History

Algert Global’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-40,467
Closed -$175K – 1303
2025
Q1 		$175K Buy
40,467
+19,020
+89% +$76.8K ﹤0.01% 1097
2024
Q4 		$69K Buy
+21,447
New +$72K ﹤0.01% 1137
2023
Q4 		– Sell
-13,525
Closed -$43K – 1227
2023
Q3 		$43K Sell
13,525
-10,680
-44% -$33.9K ﹤0.01% 1073
2023
Q2 		$80K Buy
+24,205
New +$71.5K ﹤0.01% 1042
2022
Q3 		– Sell
-20,246
Closed -$99K – 1287
2022
Q2 		$99K Sell
20,246
-30,140
-60% -$186K 0.01% 1116
2022
Q1 		$384K Buy
+50,386
New +$390K 0.03% 895

Other funds holding ORGO

SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Algert Global's ORGO Position: Q2 2025 in Review

Algert Global sold out of Organogenesis Holdings (ORGO) in Q2 2025, closing a stake of 40,467 shares — an estimated $175K sold.

Algert Global first reported a position in ORGO in Q1 2022 and held it in 6 quarters. The position peaked at $384K in Q1 2022. 115 funds tracked by Wall St. Rank hold ORGO as of Q2 2025.

  • Algert Global reported no remaining Organogenesis Holdings position as of Q2 2025 after selling out during the quarter.
  • Algert Global sold 40,467 Organogenesis Holdings shares in Q2 2025, an estimated $175K.
  • Algert Global first reported a position in Organogenesis Holdings in Q1 2022 and held it in 6 quarters.
  • Algert Global's Organogenesis Holdings position peaked at $384K in Q1 2022.
  • 115 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2025.

Based on Algert Global's 13F filing for Q2 2025, filed 14 Aug 2025.